Annual Gross Margin
62.81%
-1.46%-2.27%
31 December 2023
Summary:
Esperion Therapeutics annual gross profit margin is currently 62.81%, with the most recent change of -1.46% (-2.27%) on 31 December 2023. During the last 3 years, it has fallen by -36.14% (-36.52%). ESPR annual gross margin is now -36.52% below its all-time high of 98.95%, reached on 31 December 2020.ESPR Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
66.52%
-12.34%-15.65%
30 September 2024
Summary:
Esperion Therapeutics quarterly gross profit margin is currently 66.52%, with the most recent change of -12.34% (-15.65%) on 30 September 2024. Over the past year, it has increased by +5.90% (+9.73%). ESPR quarterly gross margin is now -33.35% below its all-time high of 99.81%, reached on 30 June 2020.ESPR Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.3% | +9.7% |
| 3 y3 years | -36.5% | +8.3% |
| 5 y5 years | - | - |
ESPR Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.5% | at low | -28.2% | +29.7% |
| 5 y | 5 years | -36.5% | at low | -33.4% | +29.7% |
| alltime | all time | -36.5% | +100.1% | -33.4% | +29.7% |
Esperion Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 66.52%(-15.6%) |
| June 2024 | - | 78.86%(-14.9%) |
| Mar 2024 | - | 92.69%(+43.7%) |
| Dec 2023 | 62.81%(-2.3%) | 64.49%(+6.4%) |
| Sept 2023 | - | 60.62%(-17.7%) |
| June 2023 | - | 73.68%(+41.4%) |
| Mar 2023 | - | 52.11%(-33.1%) |
| Dec 2022 | 64.27% | 77.89%(+18.5%) |
| Sept 2022 | - | 65.72%(+28.1%) |
| June 2022 | - | 51.30%(-17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 62.17%(-7.3%) |
| Dec 2021 | 81.88%(-17.3%) | 67.05%(+9.1%) |
| Sept 2021 | - | 61.43%(-35.7%) |
| June 2021 | - | 95.57%(+23.1%) |
| Mar 2021 | - | 77.64%(-5.9%) |
| Dec 2020 | 98.95%(-100.3%) | 82.49%(-11.1%) |
| Sept 2020 | - | 92.83%(-7.0%) |
| June 2020 | - | 99.81%(+1.5%) |
| Mar 2020 | - | 98.32% |
| Dec 2000 | -39.20 K%(-42.5%) | - |
| Dec 1999 | -68.20 K% | - |
FAQ
- What is Esperion Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Esperion Therapeutics?
- What is Esperion Therapeutics annual gross margin year-on-year change?
- What is Esperion Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly gross margin year-on-year change?
What is Esperion Therapeutics annual gross profit margin?
The current annual gross margin of ESPR is 62.81%
What is the all time high annual gross margin for Esperion Therapeutics?
Esperion Therapeutics all-time high annual gross profit margin is 98.95%
What is Esperion Therapeutics annual gross margin year-on-year change?
Over the past year, ESPR annual gross profit margin has changed by -1.46% (-2.27%)
What is Esperion Therapeutics quarterly gross profit margin?
The current quarterly gross margin of ESPR is 66.52%
What is the all time high quarterly gross margin for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly gross profit margin is 99.81%
What is Esperion Therapeutics quarterly gross margin year-on-year change?
Over the past year, ESPR quarterly gross profit margin has changed by +5.90% (+9.73%)